The condition known as polycystic ovary syndrome (PCOS) is now called polyendocrine metabolic ovarian syndrome (PMOS). The name change was announced on May 12, 2026, at the European Congress of Endocrinology in Prague and published in the medical journal, The Lancet.
Dr Veronique Viardot-Foucault, director of clinical endocrinology at the Department of Reproductive Medicine at KK Women’s and Children’s Hospital, said the idea of renaming PCOS was first raised in 1995 and revisited in 2012. Both times, it did not succeed due to a lack of global leadership, agreement on an alternative name, patient alignment and engagement.
The name change was the result of 14 years of collaboration between international societies and patient groups across six continents.
Read Full Article At Source
